49 related articles for article (PubMed ID: 10931240)
1. Amplicon rearrangements during the extrachromosomal and intrachromosomal amplification process in a glioma.
Vogt N; Gibaud A; Lemoine F; de la Grange P; Debatisse M; Malfoy B
Nucleic Acids Res; 2014 Dec; 42(21):13194-205. PubMed ID: 25378339
[TBL] [Abstract][Full Text] [Related]
2. Two novel tumours with NTRK2 fusion in the methylation class of extraventricular neurocytomas, including one intraventricular.
Uro-Coste E; Tauziede-Espariat A; Dubucs C; Chiforeanu DC; Siegfried A; Nicaise Y; Bauchet L; Riffaud L; Bielle F; Vasiljevic A; Appay R; Evrard S; Varlet P; Rigau V;
Brain Pathol; 2024 May; 34(3):e13223. PubMed ID: 37994695
[TBL] [Abstract][Full Text] [Related]
3. Differential hypermethylation of death-associated protein kinase promoter in central neurocytoma and oligodendroglioma.
Chung CL; Tsai HP; Tsai CY; Chen WT; Lieu AS; Wang CJ; Sheehan J; Chai CY; Kwan AL
Biomed Res Int; 2014; 2014():506458. PubMed ID: 24877104
[TBL] [Abstract][Full Text] [Related]
4. Something old and something new about molecular diagnostics in gliomas.
Horbinski C
Surg Pathol Clin; 2012 Dec; 5(4):919-939. PubMed ID: 23459421
[TBL] [Abstract][Full Text] [Related]
5. 1p/19q testing has no significance in the workup of glioblastomas.
Clark KH; Villano JL; Nikiforova MN; Hamilton RL; Horbinski C
Neuropathol Appl Neurobiol; 2013 Oct; 39(6):706-17. PubMed ID: 23363074
[TBL] [Abstract][Full Text] [Related]
6. Neurocytomas: long-term experience of a single institution.
Hallock A; Hamilton B; Ang LC; Tay KY; Meygesi JF; Fisher BJ; Watling CJ; Macdonald DR; Bauman GS
Neuro Oncol; 2011 Sep; 13(9):943-9. PubMed ID: 21824889
[TBL] [Abstract][Full Text] [Related]
7. Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma.
Rodriguez FJ; Mota RA; Scheithauer BW; Giannini C; Blair H; New KC; Wu KJ; Dickson DW; Jenkins RB
Brain Pathol; 2009 Oct; 19(4):623-9. PubMed ID: 18710393
[TBL] [Abstract][Full Text] [Related]
8. Fast detection of MYCN copy number alterations in brain neuronal tumors by real-time PCR.
Malakho SG; Korshunov A; Stroganova AM; Poltaraus AB
J Clin Lab Anal; 2008; 22(2):123-30. PubMed ID: 18348317
[TBL] [Abstract][Full Text] [Related]
9. Central neurocytoma: two case reports and review of the literature.
De Tommasi A; D'Urso PI; De Tommasi C; Sanguedolce F; Cimmino A; Ciappetta P
Neurosurg Rev; 2006 Oct; 29(4):339-47. PubMed ID: 16953449
[TBL] [Abstract][Full Text] [Related]
10. Neurocytoma: a comprehensive review.
Sharma MC; Deb P; Sharma S; Sarkar C
Neurosurg Rev; 2006 Oct; 29(4):270-85; discussion 285. PubMed ID: 16941163
[TBL] [Abstract][Full Text] [Related]
11. 45-year-old male with symptomatic mass in the frontal lobe.
Mueller W; Lass U; Veelken J; Reuter F; von Deimling A
Brain Pathol; 2006 Jan; 16(1):89-90, 93. PubMed ID: 16612988
[TBL] [Abstract][Full Text] [Related]
12. Primary neurocytoma of the spinal cord: a case report and review of literature.
Sharma S; Sarkar C; Gaikwad S; Suri A; Sharma MC
J Neurooncol; 2005 Aug; 74(1):47-52. PubMed ID: 16078107
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathogenesis of oligodendroglial tumors.
Jeuken JW; von Deimling A; Wesseling P
J Neurooncol; 2004 Nov; 70(2):161-81. PubMed ID: 15674476
[TBL] [Abstract][Full Text] [Related]
14. Central neurocytoma: a review.
Schmidt MH; Gottfried ON; von Koch CS; Chang SM; McDermott MW
J Neurooncol; 2004 Feb; 66(3):377-84. PubMed ID: 15015671
[TBL] [Abstract][Full Text] [Related]
15. Central neurocytomas are genetically distinct from oligodendrogliomas and neuroblastomas.
Tong CY; Ng HK; Pang JC; Hu J; Hui AB; Poon WS
Histopathology; 2000 Aug; 37(2):160-5. PubMed ID: 10931240
[TBL] [Abstract][Full Text] [Related]
16. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
17. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors.
Fujisawa H; Marukawa K; Hasegawa M; Tohma Y; Hayashi Y; Uchiyama N; Tachibana O; Yamashita J
J Neurosurg; 2002 Dec; 97(6):1350-5. PubMed ID: 12507133
[TBL] [Abstract][Full Text] [Related]
18. Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression.
Hoang-Xuan K; He J; Huguet S; Mokhtari K; Marie Y; Kujas M; Leuraud P; Capelle L; Delattre JY; Poirier J; Broët P; Sanson M
Neurology; 2001 Oct; 57(7):1278-81. PubMed ID: 11591848
[TBL] [Abstract][Full Text] [Related]
19. [Significance and prospects of study on molecular alterations in oligodendrogliomas].
Gresner SM; Liberski PP
Neurol Neurochir Pol; 2007; 41(4):333-9. PubMed ID: 17874342
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
